Capital Fund Management (CFM)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,800
Closed -$673K 1740
2020
Q1
$673K Sell
3,800
-38,300
-91% -$7.21M 0.01% 932
2019
Q4
$8.05M Sell
42,100
-31,400
-43% -$5.66M 0.06% 402
2019
Q3
$12.4M Sell
73,500
-82,800
-53% -$13.5M 0.11% 250
2019
Q2
$26.2M Buy
156,300
+35,100
+29% +$4.86M 0.24% 110
2019
Q1
$17.7M Sell
121,200
-45,800
-27% -$6.64M 0.16% 179
2018
Q4
$22.3M Sell
167,000
-94,200
-36% -$15.4M 0.2% 122
2018
Q3
$49.8M Buy
261,200
+58,100
+29% +$10.7M 0.27% 69
2018
Q2
$33.9M Sell
203,100
-64,700
-24% -$10.4M 0.18% 166
2018
Q1
$45.1M Sell
267,800
-78,000
-23% -$13.1M 0.27% 89
2017
Q4
$56.6M Buy
345,800
+278,500
+414% +$50M 0.31% 66
2017
Q3
$13.8M Buy
67,300
+35,400
+111% +$8.23M 0.1% 253
2017
Q2
$7.75M Sell
31,900
-112,400
-78% -$26.4M 0.06% 356
2017
Q1
$34.5M Sell
144,300
-77,200
-35% -$18M 0.29% 91
2016
Q4
$46.5M Buy
221,500
+201,700
+1,019% +$41.8M 0.4% 49
2016
Q3
$4.56M Buy
19,800
+7,300
+58% +$1.78M 0.04% 490
2016
Q2
$2.89M Buy
+12,500
New +$2.88M 0.03% 609
2016
Q1
Sell
-900
Closed -$281K 1982
2015
Q4
$281K Sell
900
-5,500
-86% -$1.64M ﹤0.01% 1340
2015
Q3
$1.74M Buy
+6,400
New +$1.97M 0.02% 654
2015
Q1
Sell
-25,100
Closed -$6.46M 1846
2014
Q4
$6.46M Sell
25,100
-15,100
-38% -$3.77M 0.08% 361
2014
Q3
$9.7M Sell
40,200
-69,800
-63% -$15.6M 0.11% 229
2014
Q2
$24.5M Buy
110,000
+58,900
+115% +$12.2M 0.26% 88
2014
Q1
$10.5M Buy
51,100
+28,600
+127% +$5.67M 0.13% 186
2013
Q4
$3.78M Buy
22,500
+12,700
+130% +$1.99M 0.05% 481
2013
Q3
$1.41M Sell
9,800
-45,700
-82% -$6.09M 0.02% 748
2013
Q2
$7M Buy
+55,500
New +$6.28M 0.11% 242

Other funds holding AGN

Capital Fund Management (CFM)'s AGN Position: Q2 2020 in Review

Capital Fund Management (CFM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,914 shares — an estimated $3.88M sold.

Capital Fund Management (CFM) first reported a position in AGN in Q3 2014 and held it in 11 quarters. The position peaked at $61.3M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Fund Management (CFM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 21,914 Allergan plc shares in Q2 2020, an estimated $3.88M.
  • Capital Fund Management (CFM) first reported a position in Allergan plc in Q3 2014 and held it in 11 quarters.
  • Capital Fund Management (CFM)'s Allergan plc position peaked at $61.3M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2020, filed 13 Aug 2020.